INSIDERFilingvia Quantisnow
Ortho Clinical Diagnostics Holdings plc logo

Ortho Clinical Diagnostics Holdings (OCDX) executive Busky returned to the company 398,350 Stock Option

ByQuantisnow··Wall Street's wire, on your screen.
Stocks in this Quantisnow insight

Insider transactions reported

Joseph M Busky (executive at Ortho Clinical Diagnostics Holdings plc, OCDX) reported that they returned to the company 398,350 Stock Option on May 27, 2022.

Reporting person
Busky Joseph M

Options and other derivatives

Options and other derivative transactions
DateTypeSecuritySharesPriceValueHeld after
May 27, 2022Sale back to the company (D)Stock OptionOn 398,350 Ordinary Shares, $0.00001 par value1, 2-398,350--0 direct

Holdings before and after

  • Stock Option: 398,350 to 0 direct

Footnotes from the filing

  1. 1. Pursuant to the Business Combination Agreement, dated December 22, 2021 (the BCA ), by and among Coronado Topco, Inc. ( Coronado Topco ), Laguna Merger Sub, Inc., Orca Holdco, Inc., Orca Holdco 2, Inc., Quidel Corporation and the Issuer, the Issuer became a wholly owned subsidiary of Coronado Topco upon consummation of the business combinations (the Effective Time ).
  2. 2. At the Effective Time, each stock option, whether vested or unvested, was converted into (a) a Coronado Topco stock option on the same terms and conditions as were applicable to such stock option immediately prior to the Effective Time, except as adjusted by the BCA, (b) with respect to the portion of such stock option that is vested as of the Effective Time, the right to receive payment, in cash, equal to the cash consideration payable in respect of the Issuer's securities subject to the vested portion of such stock option and (c) with respect to the portion of such stock option that is not vested as of the Effective Time, the right to receive payment, in cash, equal to the cash consideration payable in respect of the Issuer's securities subject to the unvested portion of such stock option when it vests in accordance with its terms.

Transaction codes in this filing

Sale back to the company:
Code D marks a disposition back to the company under an exempt plan, as opposed to a sale in the market.

FAQ

What did Busky report in this OCDX Form 4?

Joseph M Busky (executive at Ortho Clinical Diagnostics Holdings plc, OCDX) reported that they returned to the company 398,350 Stock Option on May 27, 2022.

What does transaction code D mean on an SEC Form 4?

Code D marks a disposition back to the company under an exempt plan, as opposed to a sale in the market.

Historical context for OCDX

Earlier insider filings at OCDX

Quantisnow market dataNASDAQ
Ortho Clinical Diagnostics Holdings plc logo
OCDX
Ortho Clinical Diagnostics Holdings plc
Market cap
30-day
Sector
Health Care
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Listed since
2021
Get push alerts for OCDX

Follow OCDX and get a push notification the moment its next story breaks.

Full OCDX profile on Quantisnow
Original source Picked up and delivered by Quantisnow in real time

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track OCDX (Ortho Clinical Diagnostics Holdings plc) and more on Quantisnow.